Found: 70
Select item for more details and to access through your institution.
Dopamine agonist-induced antecollis in Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 16, p. 2408, doi. 10.1002/mds.22779
- By:
- Publication type:
- Article
Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody–associated disease.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 8, p. 977, doi. 10.1177/13524585241254731
- By:
- Publication type:
- Article
Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 4/5, p. 530, doi. 10.1177/13524585231156736
- By:
- Publication type:
- Article
Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Minimal symptom expression achievement over time in generalized myasthenia gravis.
- Published in:
- Acta Neurologica Belgica, 2023, v. 123, n. 3, p. 979, doi. 10.1007/s13760-022-02162-1
- By:
- Publication type:
- Article
Case of convulsive seizure developing during electroretinographic recordings: a case report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response to treatment of myasthenia gravis according to clinical subtype.
- Published in:
- BMC Neurology, 2016, v. 16, p. 1, doi. 10.1186/s12883-016-0756-3
- By:
- Publication type:
- Article
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood–brain barrier disruption.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 8, p. 1072, doi. 10.1177/1352458516672015
- By:
- Publication type:
- Article
Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 10, p. 1371, doi. 10.1177/1352458515615954
- By:
- Publication type:
- Article
Benign neuromyelitis optica is rare in Japanese patients.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 9, p. 1204, doi. 10.1177/1352458514560927
- By:
- Publication type:
- Article
“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 3, p. 331, doi. 10.1177/1352458513495581
- By:
- Publication type:
- Article
Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 3, p. 378, doi. 10.1177/1352458512452332
- By:
- Publication type:
- Article
Delayed Appearance of Brain Magnetic Resonance Imaging Abnormalities in a Patient with Glial Fibrillary Acidic Protein Astrocytopathy.
- Published in:
- Internal Medicine, 2023, v. 62, n. 3, p. 465, doi. 10.2169/internalmedicine.9724-22
- By:
- Publication type:
- Article
Complete Relief of Painful Tonic Seizures in Neuromyelitis Optica Spectrum Disorder by Satralizumab Treatment.
- Published in:
- Internal Medicine, 2022, v. 61, n. 18, p. 2785, doi. 10.2169/internalmedicine.9036-21
- By:
- Publication type:
- Article
Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19.
- Published in:
- Internal Medicine, 2022, v. 61, n. 7, p. 1071, doi. 10.2169/internalmedicine.9171-21
- By:
- Publication type:
- Article
A clinical predictive score for postoperative myasthenic crisis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211006862
- By:
- Publication type:
- Article
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 2, p. 1, doi. 10.1177/20552173211006862
- By:
- Publication type:
- Article
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 2, p. 1, doi. 10.1177/2055217318759692
- By:
- Publication type:
- Article
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 1, p. 1, doi. 10.1177/2055217318759692
- By:
- Publication type:
- Article
Decreased initial compound muscle action potential amplitudes in myasthenia gravis.
- Published in:
- Neurology & Clinical Neuroscience, 2022, v. 10, n. 5, p. 245, doi. 10.1111/ncn3.12661
- By:
- Publication type:
- Article
Impaired neuromuscular transmission in facial muscles of amyotrophic lateral sclerosis: A single‐fiber electromyography study.
- Published in:
- Neurology & Clinical Neuroscience, 2022, v. 10, n. 2, p. 78, doi. 10.1111/ncn3.12580
- By:
- Publication type:
- Article
Reappraisal of Oral Steroid Therapy for Myasthenia Gravis.
- Published in:
- Frontiers in Neurology, 2020, p. N.PAG, doi. 10.3389/fneur.2020.00868
- By:
- Publication type:
- Article
Efficacy and safety of zilucoplan in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the phase III randomized RAISE study.
- Published in:
- Clinical & Experimental Neuroimmunology, 2024, v. 15, n. 1, p. 45, doi. 10.1111/cen3.12766
- By:
- Publication type:
- Article
The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome.
- Published in:
- Clinical & Experimental Neuroimmunology, 2023, v. 14, n. 1, p. 19, doi. 10.1111/cen3.12739
- By:
- Publication type:
- Article
Japan MG registry: Chronological surveys over 10 years.
- Published in:
- Clinical & Experimental Neuroimmunology, 2023, v. 14, n. 1, p. 5, doi. 10.1111/cen3.12731
- By:
- Publication type:
- Article
Anti‐striational antibodies: Expanding their clinical significance.
- Published in:
- Clinical & Experimental Neuroimmunology, 2020, v. 11, n. 4, p. 218, doi. 10.1111/cen3.12611
- By:
- Publication type:
- Article
Health‐related quality of life and treatment strategies in myasthenia gravis.
- Published in:
- Clinical & Experimental Neuroimmunology, 2020, v. 11, n. 4, p. 209, doi. 10.1111/cen3.12610
- By:
- Publication type:
- Article
Long‐term prognosis of Japanese Lambert–Eaton myasthenic syndrome patients with or without small‐cell lung carcinoma.
- Published in:
- Clinical & Experimental Neuroimmunology, 2020, v. 11, n. 2, p. 131, doi. 10.1111/cen3.12584
- By:
- Publication type:
- Article
Relationship between damage-associated molecular patterns and cytokines in myasthenia gravis.
- Published in:
- Clinical & Experimental Neuroimmunology, 2016, v. 7, n. 4, p. 357, doi. 10.1111/cen3.12331
- By:
- Publication type:
- Article
Urinary symptoms and neurological disabilities are differentially correlated between multiple sclerosis and neuromyelitis optica.
- Published in:
- Clinical & Experimental Neuroimmunology, 2016, v. 7, n. 1, p. 52, doi. 10.1111/cen3.12279
- By:
- Publication type:
- Article
The role of granulocyte-macrophage colony-stimulating factor in the pathogenesis of neuromyelitis optica: A white or black knight?
- Published in:
- Clinical & Experimental Neuroimmunology, 2015, v. 6, p. 70, doi. 10.1111/cen3.12273
- By:
- Publication type:
- Article
Validation of the Japanese version of the Modified Fatigue Impact Scale and assessment of the effect of pain on scale responses in patients with multiple sclerosis.
- Published in:
- Clinical & Experimental Neuroimmunology, 2015, v. 6, n. 4, p. 409, doi. 10.1111/cen3.12236
- By:
- Publication type:
- Article
Autoimmune polyendocrine syndrome type 3 in a multiple sclerosis patient.
- Published in:
- Clinical & Experimental Neuroimmunology, 2015, v. 6, n. 3, p. 299, doi. 10.1111/cen3.12232
- By:
- Publication type:
- Article
Multiple enhancing brain lesions after discontinuation of fingolimod in a patient with multiple sclerosis.
- Published in:
- Clinical & Experimental Neuroimmunology, 2014, v. 5, p. 52, doi. 10.1111/cen3.12163
- By:
- Publication type:
- Article
Upbeat nystagmus at caudal brainstem lesions in four cases with multiple sclerosis and its related disorders.
- Published in:
- Clinical & Experimental Neuroimmunology, 2013, v. 4, n. 2, p. 206, doi. 10.1111/cen3.12013
- By:
- Publication type:
- Article
Role of interleukin-6 in the pathogenesis of neuromyelitis optica.
- Published in:
- Clinical & Experimental Neuroimmunology, 2013, v. 4, n. 2, p. 167, doi. 10.1111/cen3.12024
- By:
- Publication type:
- Article
Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 4, p. 1996, doi. 10.1007/s00415-021-10764-7
- By:
- Publication type:
- Article
Long-term outcomes and prognostic factors in generalized myasthenia gravis.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 10, p. 3781, doi. 10.1007/s00415-021-10520-x
- By:
- Publication type:
- Article
Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 5, p. 1145, doi. 10.1007/s00415-018-8813-z
- By:
- Publication type:
- Article
Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 4, p. 1019, doi. 10.1007/s00415-015-7673-z
- By:
- Publication type:
- Article
When is neuromyelitis optica diagnosed after disease onset?
- Published in:
- Journal of Neurology, 2012, v. 259, n. 8, p. 1600, doi. 10.1007/s00415-011-6384-3
- By:
- Publication type:
- Article
Detection of mumps virus RNA in cerebrospinal fluid of patients with neuromyelitis optica.
- Published in:
- Neurological Sciences, 2011, v. 32, n. 5, p. 795, doi. 10.1007/s10072-011-0564-x
- By:
- Publication type:
- Article
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 5, p. 1338, doi. 10.1002/acn3.52051
- By:
- Publication type:
- Article
Markedly upregulated serum semaphorin 4A as a novel activity marker of myasthenia gravis.
- Published in:
- Scandinavian Journal of Immunology, 2024, v. 99, n. 5, p. 1, doi. 10.1111/sji.13360
- By:
- Publication type:
- Article
Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis.
- Published in:
- Scandinavian Journal of Immunology, 2022, v. 95, n. 2, p. 1, doi. 10.1111/sji.13122
- By:
- Publication type:
- Article
Changes in inflammatory cytokine networks in myasthenia gravis.
- Published in:
- Scientific Reports, 2016, p. 25886, doi. 10.1038/srep25886
- By:
- Publication type:
- Article
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420904207
- By:
- Publication type:
- Article
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420904207
- By:
- Publication type:
- Article
Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica.
- Published in:
- BMC Neurology, 2010, v. 10, p. 113, doi. 10.1186/1471-2377-10-113
- By:
- Publication type:
- Article